Eton Financial Statements From 2010 to 2026

Eton Pharmaceuticals Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 91.9 M 87.5 M 30.5 M Slightly volatile Other Current Liabilities 19.1 M 18.1 M 4.2 M Slightly volatile Total Current Liabilities 24.1 M 22.9 M 6.4 M Slightly volatile Total Stockholder Equity 18.6 M 28.1 M 15.7 M Slightly volatile Property Plant And Equipment Net 178.7 K 188.1 K 306.5 K Pretty Stable Accounts Payable 5 M 4.8 M 1.6 M Slightly volatile Cash 14 M 13.4 M 15.3 M Slightly volatile Non Current Assets Total 42.4 M 40.4 M 8.1 M Slightly volatile Non Currrent Assets Other 10.3 K 10.8 K 28.7 K Slightly volatile Other Assets 10.3 K 10.8 K 39.9 K Very volatile Cash And Short Term Investments 14 M 13.4 M 15.3 M Slightly volatile Common Stock Total Equity 20 K 28.8 K 15.1 K Slightly volatile Common Stock Shares Outstanding 22.6 M 29.8 M 20 M Slightly volatile Liabilities And Stockholders Equity 91.9 M 87.5 M 30.5 M Slightly volatile Non Current Liabilities Total 38.3 M 36.5 M 7.9 M Slightly volatile Capital Surpluse 82 M 133.6 M 55.8 M Slightly volatile Other Current Assets 6.6 M 6.3 M 1.8 M Slightly volatile Other Stockholder Equity 101.2 M 152.1 M 58.9 M Slightly volatile Total Liabilities 62.4 M 59.4 M 14.2 M Slightly volatile Property Plant And Equipment Gross 485.1 K 589.5 K 397.6 K Slightly volatile Total Current Assets 26.4 M 47.2 M 21.1 M Slightly volatile Net Working Capital 13.6 M 19 M 15.1 M Slightly volatile Common Stock 23.2 K 31.1 K 15.6 K Slightly volatile Property Plant Equipment 61.6 K 64.8 K 268.6 K Very volatile Capital Stock 25.6 K 31.1 K 21.4 K Slightly volatile Short and Long Term Debt Total 36.1 M 34.4 M 10.2 M Slightly volatile Net Receivables 6.5 M 6.2 M 2 M Slightly volatile Long Term Debt Total 6 M 6.2 M 5 M Slightly volatile Capital Lease Obligations 67.7 K 123 K 43 K Slightly volatile Non Current Liabilities Other 2.2 M 2.1 M 512.2 K Slightly volatile
Eton Pharmaceuticals Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 750.3 K 1.3 M 448 K Slightly volatile Selling General Administrative 14.4 M 26.2 M 10.5 M Slightly volatile Selling And Marketing Expenses 57.3 K 60.3 K 798.3 K Slightly volatile Other Operating Expenses 26.3 M 47.8 M 18.6 M Slightly volatile Research Development 5.2 M 2.9 M 5.2 M Pretty Stable Cost Of Revenue 18.8 M 17.9 M 4.3 M Slightly volatile Total Operating Expenses 21.3 M 29.9 M 15.1 M Slightly volatile Interest Income 244.8 K 323.1 K 219.4 K Slightly volatile Reconciled Depreciation 855.5 K 1.3 M 477.7 K Slightly volatile
Eton Pharmaceuticals Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Sale Purchase Of Stock 214.6 K 225.9 K 11.6 M Slightly volatile Stock Based Compensation 3.1 M 3.6 M 2.8 M Slightly volatile Other Cashflows From Financing Activities 212 K 223.2 K 8.6 M Slightly volatile Depreciation 750.3 K 1.3 M 448 K Slightly volatile Other Non Cash Items 697.3 K 1.1 M 1 M Slightly volatile Capital Expenditures 28.4 K 29.9 K 592.8 K Slightly volatile End Period Cash Flow 14 M 13.4 M 15.3 M Slightly volatile Change To Netincome 3.7 M 4.9 M 3.3 M Slightly volatile Begin Period Cash Flow 19.7 M 24.6 M 16.2 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 9.66 10.17 338 Very volatile Dividend Yield 0.0214 0.024 0.0262 Slightly volatile PTB Ratio 6.65 12.71 8.7516 Very volatile Days Sales Outstanding 54.8 57.68 151 Slightly volatile Book Value Per Share 1.22 1.08 0.9449 Pretty Stable Stock Based Compensation To Revenue 0.0886 0.0933 5.0855 Very volatile Capex To Depreciation 0.0248 0.0261 2.793 Slightly volatile PB Ratio 6.65 12.71 8.7516 Very volatile EV To Sales 10.08 10.61 312 Very volatile Inventory Turnover 0.88 0.92 2.5768 Slightly volatile Days Of Inventory On Hand 437 410 352 Very volatile Payables Turnover 3.54 3.37 1.3489 Slightly volatile Sales General And Administrative To Revenue 0.64 0.67 24.1151 Very volatile Research And Ddevelopement To Revenue 0.0912 0.096 28.4106 Very volatile Capex To Revenue 7.0E-4 8.0E-4 1.2258 Slightly volatile Cash Per Share 1.28 0.66 0.9681 Very volatile Days Payables Outstanding 107 112 7.9 K Slightly volatile Intangibles To Total Assets 0.43 0.41 0.1303 Slightly volatile Current Ratio 2.25 2.36 10.496 Slightly volatile Receivables Turnover 4.65 6.55 3.7827 Slightly volatile Shareholders Equity Per Share 1.22 1.08 0.9449 Pretty Stable Debt To Equity 1.16 1.1 0.5582 Slightly volatile Capex Per Share 9.0E-4 9.0E-4 0.028 Pretty Stable Revenue Per Share 1.42 1.36 0.4573 Slightly volatile Interest Debt Per Share 1.16 1.11 0.4228 Slightly volatile Debt To Assets 0.22 0.35 0.2694 Pretty Stable Operating Cycle 592 468 510 Very volatile Price Book Value Ratio 6.65 12.71 8.7516 Very volatile Days Of Payables Outstanding 107 112 7.9 K Slightly volatile Ebt Per Ebit 0.87 1.32 1.0525 Pretty Stable Company Equity Multiplier 1.42 2.8 1.5353 Slightly volatile Long Term Debt To Capitalization 0.26 0.49 0.3342 Slightly volatile Total Debt To Capitalization 0.27 0.5 0.3246 Slightly volatile Debt Equity Ratio 1.16 1.1 0.5582 Slightly volatile Quick Ratio 1.41 1.49 10.3044 Slightly volatile Net Income Per E B T 1.3 1.15 1.3219 Slightly volatile Cash Ratio 0.82 0.86 9.8306 Slightly volatile Days Of Inventory Outstanding 437 410 352 Very volatile Days Of Sales Outstanding 54.8 57.68 151 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.12 0.9732 1.0333 Very volatile Price To Book Ratio 6.65 12.71 8.7516 Very volatile Fixed Asset Turnover 176 168 54.7621 Slightly volatile Debt Ratio 0.22 0.35 0.2694 Pretty Stable Price Sales Ratio 9.66 10.17 338 Very volatile Asset Turnover 0.43 0.46 0.271 Slightly volatile Price Fair Value 6.65 12.71 8.7516 Very volatile
Eton Pharmaceuticals Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 82.9 M 63.8 M 96.5 M Slightly volatile Enterprise Value 71.5 M 55 M 84 M Slightly volatile

Eton Fundamental Market Drivers

Eton Upcoming Events

About Eton Pharmaceuticals Financial Statements

Pair Trading with Eton Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eton Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.When determining whether Eton Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eton Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eton Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eton Pharmaceuticals Stock:

How To Invest In Eton Details

Is Eton Stock a good investment? Details

What is Eton Pharmaceuticals' Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details